MedPath

Trauma and Cardiometabolic Health in an American Indian Community

Not Applicable
Recruiting
Conditions
Psychological Stress
Cardiometabolic Conditions
Mental Health
Registration Number
NCT06878885
Lead Sponsor
Montana State University
Brief Summary

Volunteers for the study are asked to participate in two laboratory sessions. In the first laboratory session, volunteers are asked to provide a blood sample which will be used to measure factors related to health. Participants also complete questionnaires related to demographic and health-related information and undergo evaluations of their body composition. In the second laboratory visit, participants are asked to have cardiovascular, neuroendocrine, and inflammatory activity measured during a brief period of rest and during a short challenging psychological task. Participants will also complete questionnaires. The study is designed to examine the associations between experiences such as trauma and resiliency with changes in bodily systems during a challenge and current health.

Detailed Description

This cross-sectional study will examine the association between factors of resiliency and trauma with physiological (cardiovascular, neuroendocrine, inflammatory) responses to acute stress and current mental and physical health. Study volunteers will include individuals who identify as American Indian and currently live on and near the Blackfeet Reservation. Study volunteers will be asked to provide information that will be used to measure: correlates of cardiometabolic and mental health, acute psychological stress, arterial stiffness. Results of the study will help increase knowledge of cardiometabolic and mental health in the context of past and ongoing trauma and resiliency.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
400
Inclusion Criteria
  • 18-40 years
  • Identifying as American Indian
  • Living on or near Blackfeet reservation
Exclusion Criteria
  • Uncontrolled hypertension

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Glucose5 minutes

Glucose (nmol/L) will be assessed via blood draw

Changes in systolic blood pressure activity from baseline to task10 minute resting baseline mean will be subtracted from the 4 minute task period for each value

The mean systolic blood pressure (mmHg) will be subtracted from the mean of the task period.

Changes in diastolic blood pressure activity from baseline to task10 minute resting baseline mean will be subtracted from the 4 minute task period for each value

The mean diastolic blood pressure (mmHg) will be subtracted from the mean of the task period.

Changes in heart rate activity from baseline to task10 minute resting baseline mean will be subtracted from the 4 minute task period for each value

The mean heart rate (bpm) will be subtracted from the mean of the task period.

Change in cortisol from baseline to taskBaseline will be subtracted from the peak (15 minutes after task onset, 35 minute task onset)

Salivary samples will be taken to measure cortisol (nmol/L) the mean from the peak stress period will be subtracted from the baseline

Changes in IL-6 from baseline to taskBaseline will be subtracted from the level 30 minutes after task onset.

IL-6 (pg/mL) measured at baseline will be subtracted from the IL-6 measured post task.

Pulse wave velocity5 minutes

Pulse wave velocity in m/s will be assessed by dual impedance cardiography as a non-invasive indicator of arterial stiffness. This measure will be derived from the 5 minute baseline period.

Resting systolic blood pressure10 minutes

Resting systolic blood pressure (mmHg)

Resting diastolic blood pressure10 minutes

Resting diastolic blood pressure (mmHg)

Inflammatory and anti-inflammatory cytokines5 minutes

Circulating levels of C-reactive protein, interleukin-6, tumor necrosis factor-a, monocyte chemoattractant protein-1, interleukin-1b, interleukin-10, and adiponectin will be assessed via a blood draw. A composite score will be created.

Hemoglobin A1c5 minutes

Hemoglobin A1c (nmol/L) will be assessed via blood draw

Insulin5 minutes

Insulin (mL) will be assessed via blood draw

Cholesterol5 minutes

Total cholesterol (mg) will be assessed via blood draw

Low-density lipoprotein5 minutes

Low-density lipoprotein (mg/dL) will be assessed via blood draw

High-density lipoprotein5 minutes

high-density lipoprotein (mg/dL) will be assessed via blood draw

Triglycerides5 minutes

Triglycerides (mmol/L) will be assessed via blood draw

Waist circumference2 minutes

Waist circumference

Hip circumference2 minutes

Hip circumference

Depressive symptomology (Hospital Anxiety Depression Questionnaire depression subscale)10 minutes

Hospital Anxiety Depression Questionnaire (depression subscale)

Depressive symptomology (PHQ-9)10 minutes

PHQ-9

Anxiety symptomtology5 minutes

Hospital Anxiety Depression Questionnaire (Anxiety subscale)

Alcohol use10 minutes

Alcohol use will be assessed using the Alcohol Use Identification Test

Substance use5 minutes

A cumulative score of substance use will be reported by indicating the number of recreational drugs "ever" tried

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Blackfeet Community College

🇺🇸

Browning, Montana, United States

Blackfeet Community College
🇺🇸Browning, Montana, United States
Betty Henderson-Matthews, MA
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.